Preparing Pharmacists for The Era of AI-driven Pharmacological Sciences: An Opinion Article
Keywords:
Artificial Intelligence (AI), AI-driven Pharmacological Science, AI-based Genomic Sequencing, AI-driven Personalized Medicine, Pharmacy EducationAbstract
Due to its rapid development, artificial intelligence (AI) has gained a lot of popularity in many sectors, including pharmacological sciences. In pharmacological sciences, AI has been applied in various areas, from AI-driven drug discovery and genomic sequencing to the development of personalized medicine. Subsequently, the need for pharmacists with adequate AI-related skills and knowledge increases. However, the current traditional curriculum of pharmacy education does not cover AI courses. To elaborate on the current developments in AI-driven pharmacology and present the discussion of the possibility of whether AI-related courses should be included in the current curriculum. We have gathered 32 references on AI-driven pharmacological applications, pharmacy curricula, and the future trends of pharmacological sciences. The literature is obtained from online databases such as Scopus, PubMed, IEEE, and Google Scholar. Based on the literature reviews, we presented the discussion and scientific-based opinion on the need for AI-related courses in the school of pharmacy. We believe that AI will be the basis of future pharmacological development. Hence, we consider that it is the right time to include AI-related courses in the student's curriculum to prepare future-proof pharmacists.
Downloads
References
Chan, H. S., Shan, H., Dahoun, T., Vogel, H., & Yuan, S. (2019). Advancing drug discovery via artificial intelligence. Trends in pharmacological sciences, 40(8), 592-604.
Smalley, E. (2017). AI-powered drug discovery captures pharma interest. Nature Biotechnology, 35(7), 604-606.
Najafi, S. (2020). The use of ai on drug testing. International Journal of Modern Engineering Technologies, 2(1).
Mohanty, S., Rashid, M. H. A., Mridul, M., Mohanty, C., & Swayamsiddha, S. (2020). Application of Artificial Intelligence in COVID-19 drug repurposing. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 1027-1031.
Basile, A. O., Yahi, A., & Tatonetti, N. P. (2019). Artificial intelligence for drug toxicity and safety. Trends in pharmacological sciences, 40(9), 624-635.
Schork, N. J. (2019). Artificial intelligence and personalized medicine. In Precision medicine in cancer therapy (pp. 265-283). Springer, Cham.
Awwalu, J., Garba, A. G., Ghazvini, A., & Atuah, R. (2015). Artificial intelligence in personalized medicine application of AI algorithms in solving personalized medicine problems. International Journal of Computer Theory and Engineering, 7(6), 439.
Zhang, L., Tan, J., Han, D., & Zhu, H. (2017). From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug discovery today, 22(11), 1680-1685.
Farghali, H., Canová, N. K., & Arora, M. (2021). The potential applications of artificial intelligence in drug discovery and development. Physiological Research, 70(Suppl 4), S715.
Soni, K., & Hasija, Y. (2022, February). Artificial Intelligence Assisted Drug Research and Development. In 2022 IEEE Delhi Section Conference (DELCON) (pp. 1-10). IEEE.
Burki, T. (2020). A new paradigm for drug development. The Lancet Digital Health, 2(5), e226-e227.
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015). Deep neural nets as a method for quantitative structure–activity relationships. Journal of chemical information and modeling, 55(2), 263-274.
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., ... & Aspuru-Guzik, A. (2019). Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nature biotechnology, 37(9), 1038-1040.
Fooshee, D., Mood, A., Gutman, E., Tavakoli, M., Urban, G., Liu, F., ... & Baldi, P. (2018). Deep learning for chemical reaction prediction. Molecular Systems Design & Engineering, 3(3), 442-452.
Avdagic, Z., Purisevic, E., Omanovic, S., & Coralic, Z. (2009). Artificial intelligence in prediction of secondary protein structure using CB513 database. Summit on translational bioinformatics, 2009, 1.
Popova, M., Isayev, O., & Tropsha, A. (2018). Deep reinforcement learning for de novo drug design. Science advances, 4(7), eaap7885.
Yin, Z., Ai, H., Zhang, L., Ren, G., Wang, Y., Zhao, Q., & Liu, H. (2019). Predicting the cytotoxicity of chemicals using ensemble learning methods and molecular fingerprints. Journal of Applied Toxicology, 39(10), 1366-1377.
Maciukiewicz, M., Marshe, V. S., Hauschild, A. C., Foster, J. A., Rotzinger, S., Kennedy, J. L., ... & Geraci, J. (2018). GWAS-based machine learning approach to predict duloxetine response in major depressive disorder. Journal of psychiatric research, 99, 62-68.
Wei, Z., Wang, W., Bradfield, J., Li, J., Cardinale, C., Frackelton, E., ... & International IBD Genetics Consortium. (2013). Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. The American Journal of Human Genetics, 92(6), 1008-1012.
Wei, Z., Wang, K., Qu, H. Q., Zhang, H., Bradfield, J., Kim, C., ... & Hakonarson, H. (2009). From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS genetics, 5(10), e1000678.
Díez Díaz, F., Sánchez Lasheras, F., Moreno, V., Moratalla-Navarro, F., Molina de la Torre, A. J., & Martín Sánchez, V. (2021). GASVeM: a new machine learning methodology for multi-SNP analysis of GWAS data based on genetic algorithms and support vector machines. Mathematics, 9(6), 654.
Deneke, C., Rentzsch, R., & Renard, B. Y. (2017). PaPrBaG: A machine learning approach for the detection of novel pathogens from NGS data. Scientific reports, 7(1), 1-13.
Bhinder, B., Gilvary, C., Madhukar, N. S., & Elemento, O. (2021). Artificial intelligence in cancer research and precision medicine. Cancer Discovery, 11(4), 900-915.
Uddin, M., Wang, Y., & Woodbury-Smith, M. (2019). Artificial intelligence for precision medicine in neurodevelopmental disorders. NPJ digital medicine, 2(1), 1-10.
Porumb, M., Stranges, S., Pescapè, A., & Pecchia, L. (2020). Precision medicine and artificial intelligence: a pilot study on deep learning for hypoglycemic events detection based on ECG. Scientific reports, 10(1), 1-16.
Praktik, S. (2022). Emergent neural networks to redesign clinical testing of medicines and learning from real world evidence. Retrieved 29 June 2022, from https://www.pratiks.info/research/mit/emergent-neural-networks-to-redesign-clinical-testing-of-medicines-and-learning-from-real-world-evidence
Association of Indonesian Pharmacy Higher Education. (2013). Academic Script: Graduate Competencies Standard and Pharmacy Education Curriculum Standard for Undergraduate and Apothecary Study Program. Education Development Commission AIPHE.
Indonesian Ministry of Health. (2016). Core Curriculum of Vocational Pharmacy Education. Health Human Resources Development and Empowerment Agency.
Cokro, F., Atmanda, P. F. K., Sagala, R. J., Arrang, S. T., Notario, D., Rukmini, E., & Aparasu, R. (2021). Pharmacy Education in Indonesia. Pharmacy Education, 21, 432-442.
Basak, S.C., & Sathyanarayana, D. (2010). Pharmacy education in India. American Journal of Pharmaceutical Education, 74(4), 68. PubMed.
Chanakit, T., Low, B.Y., Wongpoowarak, P., Moolasarn, S., & Anderson, C. (2014). A Survey of Pharmacy Education in Thailand. American Journal of Pharmaceutical Education, 78(9), 161.
Vo, T.-H., Bedouch, P., Nguyen, T.-H., Nguyen, T.-L.-H., Hoang, T.-K.-H., Calop, J., & Allenet, B. (2013). Pharmacy education in Vietnam. American Journal of Pharmaceutical Education, 77(6), 114. PubMed.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Urfa Khairatun Hisan, Rizqi Dinni Fauzia, Muhammad Miftahul Amri
![Creative Commons License](http://i.creativecommons.org/l/by-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.